Aligos Therapeutics (ALGS) Other Working Capital Changes (2021 - 2025)
Historic Other Working Capital Changes for Aligos Therapeutics (ALGS) over the last 5 years, with Q3 2025 value amounting to -$796000.0.
- Aligos Therapeutics' Other Working Capital Changes fell 1387.7% to -$796000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year increase of 1280.79%. This contributed to the annual value of -$2.7 million for FY2024, which is 6705.59% up from last year.
- As of Q3 2025, Aligos Therapeutics' Other Working Capital Changes stood at -$796000.0, which was down 1387.7% from -$997000.0 recorded in Q2 2025.
- In the past 5 years, Aligos Therapeutics' Other Working Capital Changes registered a high of $12.4 million during Q1 2022, and its lowest value of -$14.9 million during Q3 2022.
- Its 5-year average for Other Working Capital Changes is -$559578.9, with a median of -$910000.0 in 2021.
- Data for Aligos Therapeutics' Other Working Capital Changes shows a peak YoY increase of 146681.32% (in 2022) and a maximum YoY decrease of 87020.17% (in 2022) over the last 5 years.
- Aligos Therapeutics' Other Working Capital Changes (Quarter) stood at $12.1 million in 2021, then tumbled by 95.25% to $573000.0 in 2022, then crashed by 359.16% to -$1.5 million in 2023, then skyrocketed by 51.92% to -$714000.0 in 2024, then decreased by 11.48% to -$796000.0 in 2025.
- Its Other Working Capital Changes stands at -$796000.0 for Q3 2025, versus -$997000.0 for Q2 2025 and -$502000.0 for Q1 2025.